United States (US) Fibromyalgia Treatment Market (2025-2031) | Share, Value, Trends, Companies, Growth, Forecast, Analysis, Outlook, Size & Revenue, Industry, Segmentation, Competitive Landscape

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3.1 United States (US) Country Macro Economic Indicators

3.2 United States (US) Fibromyalgia Treatment Market Revenues & Volume, 2021 & 2031F

3.3 United States (US) Fibromyalgia Treatment Market - Industry Life Cycle

3.4 United States (US) Fibromyalgia Treatment Market - Porter's Five Forces

3.5 United States (US) Fibromyalgia Treatment Market Revenues & Volume Share, By Drug Class, 2021 & 2031F

3.6 United States (US) Fibromyalgia Treatment Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing prevalence of fibromyalgia in the US

4.2.2 Growing awareness and diagnosis rates of fibromyalgia

4.2.3 Advancements in research leading to new treatment options

4.3 Market Restraints

4.3.1 High cost associated with fibromyalgia treatment

4.3.2 Limited efficacy and side effects of current treatment options

4.3.3 Lack of definitive diagnostic tools for fibromyalgia

6.1 United States (US) Fibromyalgia Treatment Market, By Drug Class

6.1.1 Overview and Analysis

6.1.2 United States (US) Fibromyalgia Treatment Market Revenues & Volume, By Drug Class, 2021- 2031F

6.1.3 United States (US) Fibromyalgia Treatment Market Revenues & Volume, By Antidepressants, 2021- 2031F

6.1.4 United States (US) Fibromyalgia Treatment Market Revenues & Volume, By Anticonvulsants, 2021- 2031F

6.1.5 United States (US) Fibromyalgia Treatment Market Revenues & Volume, By Muscle Relaxants, 2021- 2031F

6.1.6 United States (US) Fibromyalgia Treatment Market Revenues & Volume, By Others, 2021- 2031F

6.2 United States (US) Fibromyalgia Treatment Market, By Distribution Channel

6.2.1 Overview and Analysis

6.2.2 United States (US) Fibromyalgia Treatment Market Revenues & Volume, By Hospital pharmacies, 2021- 2031F

6.2.3 United States (US) Fibromyalgia Treatment Market Revenues & Volume, By Drug stores and retail pharmacies, 2021- 2031F

6.2.4 United States (US) Fibromyalgia Treatment Market Revenues & Volume, By Online providers, 2021- 2031F

7.1 United States (US) Fibromyalgia Treatment Market Export to Major Countries

7.2 United States (US) Fibromyalgia Treatment Market Imports from Major Countries

8.1 Average waiting time for fibromyalgia diagnosis

8.2 Patient satisfaction with available treatment options

8.3 Number of clinical trials for new fibromyalgia treatments

8.4 Percentage of healthcare providers trained in fibromyalgia management

8.5 Patient adherence to prescribed treatment regimens

9.1 United States (US) Fibromyalgia Treatment Market Opportunity Assessment, By Drug Class, 2021 & 2031F

9.2 United States (US) Fibromyalgia Treatment Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F

10.1 United States (US) Fibromyalgia Treatment Market Revenue Share, By Companies, 2024

10.2 United States (US) Fibromyalgia Treatment Market Competitive Benchmarking, By Operating and Technical Parameters